Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas
about
GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitisProtein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancerMethylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemiaDownregulation of miR-122 in the rodent and human hepatocellular carcinomasMethylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisProtein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-925-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signalA folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 ratsIdentification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cellsDNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2Role of protein tyrosine phosphatases in cancerThe protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesisCholine, Other Methyl-Donors and Epigenetics.Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanibDNA methylation of cancer genome.Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer.Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet.Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period.Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse modelPTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesisTechniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformationTargeting the PTPome in human disease.Protein-tyrosine phosphatases and cancer.Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expressionEpigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivityRole of protein-tyrosine phosphatases in regulation of osteoclastic activity.PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapyBCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2Role of estrogen in hepatocellular carcinoma: is inflammation the key?
P2860
Q24313112-6DDF11B7-518B-4F82-887E-27D3BF1315E2Q24564615-FDDECA16-A643-43FE-9656-7B9F7F32CA49Q24619893-80641379-35A7-44A5-B895-75931862BF4CQ24631076-3F24CE4A-86D9-40FD-8DEF-96C70163294FQ24656948-CCFB4D23-56AB-42B6-B73C-FA1BDE10B606Q28288074-E6AFD017-9B3F-47CD-90A1-5477500B6B59Q28384242-25EDE629-BF7F-44FB-A67B-8182CF5F616AQ28566367-C9609B44-1F99-42D6-815F-FE8F83320F45Q28580458-568B5571-370A-43AB-A9D3-DFCD610134CDQ28584099-46CB1D76-92B1-4554-9B68-13F8A08A5558Q28741003-B3187CB8-EF52-4DA3-8072-514586722FFDQ33571397-1A3188EC-F539-4441-9097-407069650D98Q33749246-483BB722-83E4-4DDE-8605-47A11AC9207BQ33775528-22DE8C3B-AFB1-496F-BDB7-85C77BCF4B7BQ33828327-837E6FF4-21AC-435D-85AD-B11C6CB3248CQ33952692-F6D84916-1DF5-4C87-AB29-785BC3B76AADQ34133706-6AD367EC-332C-4D5F-BB42-38486929B3F8Q34225341-56E6DF4A-7620-4258-ACCE-6C1A2DF29A60Q34308099-D10CC27F-2DF4-40A3-953F-7DD680A2B71AQ34336836-BE505192-9CBF-42E0-8924-AF3FFDB112AAQ34349289-9E5E0FDE-36BA-48B1-A8DC-1B16ACB86371Q34384312-96E3A4C3-16FD-4C0C-B0FD-3E0C89CDC73CQ34528296-B5F1E18C-5EB7-4B31-B4DC-21AC7CF4809AQ34684583-23C8A35C-7CEB-4F9C-98DF-9F3A654F4EC5Q35553581-45246785-C45F-455B-A988-EAA1DDCF6C8AQ35643156-1FB658C1-AF08-4996-AFE0-B4188F24ED3BQ35685290-08FF8693-242B-4692-9118-295E9E7A4049Q35832384-88162FCB-7190-4234-AABF-16108E0FD0BDQ36108445-30F9A299-43C3-483D-AF81-0973178C4BCCQ36277279-9789E416-91E9-4C88-A923-EBC95CA2EADEQ36379394-965E9A96-F9F5-4777-82B6-EADC96A7D7DAQ36430193-3EDF7AC3-80EA-4135-BAAD-F2744F2F0C58Q36459023-4FA9EDAF-230B-4FD7-9739-2BCBAA3D6E36Q36945640-5384AFD7-C0A2-41C0-A0DD-94DC30A3AA42Q37106891-AB5294D8-6CCA-4B11-9FE4-6DE97D99146EQ37263070-55597883-A900-4E19-A3C2-77354AC3A8BCQ37367387-5C51729A-9A24-49C9-B512-3BA5FAA33742Q37484499-6410D612-30B9-4FE8-9E71-EBE019BA78B8Q37609203-C54E65A7-30FE-45D5-A733-455FFCB46E6FQ37710885-3974E1E8-3734-4E58-86AC-3D9E0C4C045A
P2860
Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@ast
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@en
type
label
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@ast
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@en
prefLabel
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@ast
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@en
P2093
P2860
P356
P1433
P1476
Suppression of the protein tyr ...... n in hepatocellular carcinomas
@en
P2093
Anindita Das
Christoph Plass
Dieter Weichenhan
Kalpana Ghoshal
Kristen Holman
S Jill James
Samson T Jacob
Sarmila Majumder
Tasneem Motiwala
Yue-Zhong Wu
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206750
P407
P577
2003-09-01T00:00:00Z
P5875
P6179
1019355024